The combination of gemcitabine and cisplatin as neoadjuvant chemotherapy for early stage non-small cell lung carcinoma (NSCLC): An interim analysis of a phase II trial.

dc.contributor.author	Yazar, A
dc.contributor.author	Cakan, A
dc.contributor.author	Turna, A
dc.contributor.author	Dilege, S
dc.contributor.author	Goksel, T
dc.contributor.author	Aydiner, A
dc.contributor.author	Kiyik, M
dc.contributor.author	Cikrikcioglu, S
dc.contributor.author	Kosar, F
dc.contributor.author	Gurses, A
dc.date.accessioned	2021-03-04T08:12:02Z
dc.date.available	2021-03-04T08:12:02Z
dc.identifier.citation	Aydiner A., Kiyik M., Cikrikcioglu S., Kosar F., Gurses A., Turna A., Yazar A., Dilege S., Goksel T., Cakan A., "The combination of gemcitabine and cisplatin as neoadjuvant chemotherapy for early stage non-small cell lung carcinoma (NSCLC): An interim analysis of a phase II trial.", 41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 13 - 17 Mayıs 2005, cilt.23
dc.identifier.other	vv_1032021
dc.identifier.other	av_621e9a11-fe89-489d-baf0-a56eab07b06a
dc.identifier.uri	http://hdl.handle.net/20.500.12627/68343
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Klinik Tıp
dc.subject	ONKOLOJİ
dc.title	The combination of gemcitabine and cisplatin as neoadjuvant chemotherapy for early stage non-small cell lung carcinoma (NSCLC): An interim analysis of a phase II trial.
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	23
dc.contributor.firstauthorID	130946

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.